Hanmi Pharm. Co., Ltd.

Other

Korea Institute of Science and Technology

Korea Institute of Radiological & Medical Sciences

Hanmi Holdings Co., Ltd.

Eun Sook Kim

Sangmin Yun

Gwan Sun Lee

Kwee Hyun Suh

Cheol Kyung Kim

Bo Sung Kwon

Kwee-Hyun Suh

Hee Cheol Kim

Mi Young Ko

Hee Seock Kim

Tae Hee Ha

Youngsoon Um

Gyeongtaek Gong

Han Kyong Kim

Han Min Woo

Jie Young Song

Sang Min Yun

Sang Woo Bae

Hee Chung Kwon

Sukhyeong Cho

Cheol Kyung Sinnamusil Shinwon Apt 642-602 Kim

Mi Young Cheongmyung Daewoo Apt 303-1204 Ko

Kwee Hyun Greenville Apt 101-204 Suh

Cheol Kyung Jugong 2-Cha Apt 201-402 Kim

Kwee-Hyun Greenvill Apt 101-204 Suh

Kwang Seok Kim

Kyu Jin Choi

Disclosed is a method of preparing a knitting yarn having a water-repellent function, including providing a knitting yarn in the form of a skein or a cone, washing the provided yarn to remove impurities and oil therefrom, coating the washed yarn with a water-repellent agent by spraying a water repellent solution containing the water-repellent agent at a predetermined pressure, dehydrating and drying the coated yarn, and fixing the water-repellent agent to the yarn by applying heat to the dried yarn.

Method for preparing knitting yarn having water repellent function

The present disclosure relates to a novel strain capable of saccharifying and fermenting biomass-derived cellulose and a recombinant strain thereof with improved biomass saccharification capability. The present disclosure also relates to a method for producing a material useful as a bioenergy source material such as ethanol, acetic acid, formic acid, etc. using the strain or the recombinant strain. The strain or the recombinant strain may be usefully used in bioenergy industry.

[object Object]

Provided are a method of enhancing radiation sensitivity by using miR-499b-5p and a method of treating a radiation resistant cancer including administering miR-499b-5p.

Composition comprising miRNA for enhancing radiation sensitivity

Optically pure clopidogrel can be prepared in a high yield by optically resolving a racemic form of the compound of formula (II) using an optically active amine to form the optically active form of the compound of formula (III) or its acid-addition salt; and methylating the compound of formula (III) or its acid-addition salt.

Method preparation clopidogrel and intermediates used therein

Method of preparing clopidogrel and intermediates used therein

The present invention relates to a method for preparing clopidogrel 1,5-naphthalenedisulfonate or a hydrate thereof, which comprises reacting a clopidogrel-acid addition salt with disodium 1,5-naphthalenedisulfonate or its hydrate in water, or a mixture of water and an organic solvent. High quality clopidogrel 1,5-naphthalenedisulfonate can be prepared by the inventive method by way of using non-corrosive disodium 1,5-naphthalenedisulfonate.

Method for preparing clopidogrel 1,5-naphthalenedisulfonate or hydrate thereof

A crystalline clopidogrel naphthalenesulfonate or a hydrate thereof, a method for preparing same, and a pharmaceutical composition containing same are provided.

Crystalline monohydrate clopidogrel naphthalenedisulfonate and process of preparation

Ticlopidine and clopidogrel having high blood platelet aggregation inhibitory and anti-thrombotic activities are simply prepared by reacting a substituted thiophene derivative with a 2-chlorobenzylamine derivative.

Method of preparing thieno[3,2-c]pyridine derivatives and intermediates used therein

Growing community of inventors

Seoul, South Korea

Eun Sook Kim